Crosswalk/Substantive Change

Part_D_Summ_2024_Application_Revisions_technical__substantive_30 Day.docx

Solicitation for Applications for Medicare Prescription Drug Plan 2024 Contracts (CMS-10137)

Crosswalk/Substantive Change

OMB: 0938-0936

Document [docx]
Download: docx | pdf

9/28/2022

Summary of Substantive and Technical Changes for

All Part D Application Revisions from 2023 Version of Part D Application to 2024


Substantive Changes


Clarification

Purpose of Clarification

PDP/MAPD

PACE

Change in Burden

Add attestation that applicant has not filed for been placed under bankruptcy proceedings.

To allow CMS to enforce the past performance requirements of 42 CFR § 423.503(b)(1).

p.28

p. 13

.02 hours



Technical Changes


Clarification

Purpose of Clarification

PDP/MAPD


PACE

  1. Changed dates throughout document to reflect changes for 2024 application cycle.


To reflect changes for 2024 cycle.

Throughout document

Throughout document

  1. Grammatical and wording changes.

To enhance readability.

Throughout document

Throughout document

  1. Updated information for LTC facility list.

To provide a more accurate and frequently updated source.

Section 2.6.3

N/A

  1. Added language for transition policy.

To describe the requirements of transition policy.

Section 1.4

N/A

NOTE 1: Nothing in the technical changes table increases burden on the applicant.



2

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleOMB Application Review Table
AuthorMarla Rothouse
File Modified0000-00-00
File Created2022-10-14

© 2024 OMB.report | Privacy Policy